Join
Live feed
·
PRReleasevia Quantisnow
RAPT Therapeutics Inc. logo

RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon

ByQuantisnow·Wall Street's wire, on your screen.
RAPT· RAPT Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RAPT (RAPT Therapeutics Inc.) and more on Quantisnow.